The state of Michigan has recognized the presence of Mycobacterium bovis in its free-ranging white-tailed deer population since 1994. This endemic infection is primarily located in a 12-county area in the northeastern lower peninsula of Michigan. A statewide surveillance and eradication program of the disease has been in effect since 1994. Worldwide, Mycobacterium tuberculosis complex organisms have a known predilection toward development of antimicrobial resistance. The objective of this study was to investigate the antimicrobial susceptibility of M. bovis isolates from white-tailed deer in Michigan and detect any changes in susceptibility over time. M. bovis isolates from 2 fall hunting seasons (1999 and 2004) were used in this study. The fall season of 2004 marked the first documented case of direct transmission of M. bovis from a wild deer to a human in Michigan. Since M. bovis is a zoonotic disease, knowledge of susceptibility can expedite treatment options in humans. M. bovis isolates were obtained from 58 deer, 4 coyotes, 3 cattle, 2 raccoons, and 1 human case from the 2 years combined. Methods of susceptibility testing included 1% proportion agar plates and Bactec radiometric broth testing. M. bovis was found to be uniformly resistant to the antibiotic pyrazinamide; this resistance is common to all M. bovis isolates. No other antimicrobial resistance was found in any of the tested M. bovis isolates, which may be, in part, attributed to the lack of any significant treatment pressure in wildlife.
<!?show "fnote_aff1"$^!"content-markup(./author-grp [1] /aff|./author-grp [1] /dept-list)> White-tailed deer (Odocoileus virginianus) have been recognized as a primary reservoir of Mycobacterium bovis in Michigan. 13 Since 1994, the state of Michigan has implemented a free-ranging deer tuberculosis surveillance and eradication program. This program radiates from a 12county area in the northeastern lower part of Michigan. 15 In addition to the wild white-tailed deer, several other species, including various free-ranging carnivores, have been tested for M. bovis. 15 Specifically, several coyotes, raccoons, opossums, and black bears have been found positive for M. bovis. The route of infection of these noncervid wildlife species is thought to be oral, by consuming M. bovis-infected deer carcass remnants or other infected feedstuffs. 4 Worldwide, tuberculosis is considered a leading cause of death in humans, with one-third of the world's population currently infected. 2 A serious concern is the development of multidrug resistant (MDR) tuberculosis, which is defined as tuberculosis bacilli that are resistant to isoniazid and rifampin, with or without additional antimicrobial resistance. 2 Multidrug resistant strains of M. bovis have been identified worldwide, and, with the ease and frequency of human foreign travel, international spread of these strains is of concern. Indeed, cases of MDR tuberculosis have already been seen as close to Michigan as Canada. 11 M. bovis is a zoonotic disease, and development of multidrug resistance within the strain of M. bovis that is currently endemic in the deer in Michigan is a public health concern.
Until recently, the zoonotic threat posed by the freeranging deer population in Michigan has been considered minimal. Information has been made available to deer hunters with regard to safe handling of carcasses and venison, and educational materials describing the identification of tuberculosis lesions have been disseminated to hunters. This information has been made available to the public since 1996 by the Michigan Department of Natural Resources on its web site and in annual hunting guides. 1 The biggest concern for human exposure is to those hunters who field-dress deer carcasses and come into contact with tuberculous lesions. 18 6, 2005) . The deer had exhibited scattered 1-2-cm-diameter nodules throughout its lungs and pleura. Initially, the hunter had a small puncture wound (less than 0.5-cm diameter) at the base of his index finger; however, within 2 weeks the base of the finger became swollen and painful and did not respond to standard antibiotic therapy. Upon a second examination, the wound was drained and cultured; M. bovis was isolated from the wound site and was confirmed to be the same strain, as determined by mycobacterial interspersed repetitive units (MIRU) and spoligotyping methods, as found in the white-tailed deer. This was the first reported case of direct deer to human transmission.
In light of the recent human exposure, it is important to know the pattern of antimicrobial resistance in Michigan's endemic strain of M. bovis. Therefore, the objective of this study was to investigate the antimicrobial susceptibility of M. bovis isolated from white-tailed deer and other positive species in the state. The antimicrobials tested were isoniazid (INH), streptomycin (SM), rifampin (RA), ethambutol (EMB), ethionamide (EA), kanamycin (K), ciprofloxacin (CIP), cycloserine (CS), capreomycin (CM), and pyrazinamide (PZA). Isolates were obtained from 58 deer (30 in 1999; 28 in 2004), 4 coyotes (3 in 1999; 1 in 2004), 3 cattle (all in 1999), 2 raccoons (both in 1999), 1 bear (1999 only), and 1 human case of M. bovis from the hunter who contracted M. bovis in 2004; the isolate cultured from the deer responsible for the hunter's exposure was also included in this study. The MIRU and spoligotyping methods were used to determine whether the isolates were all of the same deer strain of M. bovis and were performed by the Michigan Department of Community Health. 17 All Michigan M. bovis isolates tested during the last 2 years have been identical by the above testing methods; earlier restriction fragment length polymorphism (RFLP) testing of several hundred isolates obtained in the mid-1990s also documented the similarity of M. bovis isolates.
Culture isolates were subcultured into Middlebrook 7H9 broth a and incubated at 35uC for 2 to 6 days. These subcultures were used to perform 1% proportion plate susceptibility testing according to previously described techniques. 10 Middlebrook 7H10 agar plates a were prepared by dispensing 5 ml of medium into quadrant Petri dishes with drug-impregnated discs a in each quadrant and 1 drug-free quadrant to serve as a control. Powdered suspensions were used for preparation of CS and CM. Final drug concentrations in the plates were: INH (0.2 and 1.0 mg/ml); SM (2.0 and 10.0 mg/ml); RA (1.0 mg/ml); EMB (5.0 mg/ml); EA (5.0 mg/ml); K (6 mg/ml); CIP (2.0 mg/ml); CS (30.0 mg/ml); and CM (10.0 mg/ml). Plates were inoculated to achieve a colony count of between 100 to 300 colony forming units per plate quadrant. They were incubated at 35uC with CO 2 for 3 weeks. The percentage resistance was calculated for each drug using the following formula:
Number of colonies on the drug quadrant Number of colonies on the control quadrant
| 100
% Resistance
The interpretation of resistance was based upon a 1% standard cutoff. A culture with a percent resistance of ,1% was considered susceptible to that drug at that concentration. A culture with a percent resistance of $1% was considered resistant to the drug at that concentration. Bactec radiometric susceptibility testing was also performed on each culture isolate according to previously described methods. 16 Four antibiotics were added to the Bactec 12B vials. a The following drugs and concentrations were tested: SM (2.0 mg/ml); INH (0.1 mg/ml); RA (2.0 mg/ ml); and EMB (2.5 mg/ml). A suspension of each isolate was diluted to a 0.5 MacFarland suspension and inoculated into the vials containing drugs. A drug-free control vial was also prepared using a 1 : 100 dilution of the 0.5 MacFarland suspension. Vials were read daily using the Bactec 460 TB instrument a until the growth index (GI) of the control vials reached 30 or greater. Susceptibility results were determined by comparing the DGI (difference between the most recent GI value and the GI from the previous day) of the drug vial to the DGI of the control vial. A resistant isolate had a DGI greater than the DGI of the control vial.
The Bactec PZA method was also tested for each isolate. 16 A 0.5 MacFarland suspension of the isolate was inoculated into a Bactec 12B vial and grown to a GI of greater than 300, then inoculated into 2 separate PZA test medium vials. a Pyrazinamide drug was added to 1 vial at a final concentration of 100 mg/ml, and the other drug-free vial served as the control. Vials were read daily using the Bactec 460 TB instrument until the control GI reached greater than or equal to 200.
Bactec PZA results were interpreted using the following formula:
GI drug vial GI control vial | 100~% Resistance
Percentage of resistance less than 9% was interpreted as ''susceptible.'' Percent of resistance greater than 11% was interpreted as ''resistant.'' Percentage of resistance between 9% and 11% was considered borderline and required repeat testing; however, this result was extremely uncommon in the laboratory. As expected for M. bovis, all isolates were found to be PZA resistant (Table 1) . M. bovis is inherently resistant to PZA because it fails to produce the enzyme pyrazinamidase. 3 This enzyme is required to convert PZA to pyrazinoic acid, which subsequently prevents growth of M. bovis. 8 No other antimicrobial resistance was noted (Table 1) using either the Bactec or 1% proportion plate methods. These results were identical between the 1999 and the 2004 samples analyzed.
No resistance was demonstrated in the endemic strain of M. bovis in Michigan in either 1999 or 2004, except for the expected resistance to PZA. These results are not surprising, given the lack of treatment pressure upon this endemic strain of M. bovis. Positive domestic animals are slaughtered, not treated and released, and wildlife positives are always detected following harvest of the affected animal. Increased hunter harvest of wild deer and regulatory restrictions applied both statewide and more stringently in endemic tuberculosis counties limiting supplemental feeding that brings many deer together in close proximity has resulted in a decline in M. bovis-infected wildlife over the past 10 years. 14 Whereas these practices are helpful in limiting the development of antimicrobial resistance, they do not eliminate the potential for it. Other factors, such as random mutation of the organism, can also contribute to development of resistance. Spontaneous mutations in M. tuberculosis isolates resulting in drug resistance occur at reported frequencies between 1.0 3 10 27 and 2.95 3 10 28 . 6 There are many reports of MDR strains of M. bovis emerging in humans in Europe and throughout other less developed countries throughout the world. 5, 7 Although development of MDR strains of M. bovis is less frequently reported than MDR strains of M. tuberculosis, it is still a problem, especially in countries that continue to have high rates of M. bovis infection in their milking goats and cattle. 12 This study included the isolate from the first human case directly linked to the endemic Michigan strain of M. bovis. As a result of his injury, the hunter acquired a cutaneous M. bovis infection. He was treated successfully with the standard therapy following Centers for Disease Control and Prevention recommendations for M. bovis (Spieldenner, 2005, personal communication), which included treatment with isoniazid, rifampin, and ethambutol. 9 As this case demonstrates, knowledge of the antimicrobial resistance of this strain of M. bovis is crucial to the prompt and successful treatment of humans when exposed. Although most M. bovis isolates are tested for antimicrobial sensitivity, this is not commonly done at primary health care providers, but is forwarded to reference labs such as the Tuberculosis Laboratory, Michigan Department of Community Health. These samples are routinely held in culture conditions for up to 8 weeks before completing isolation and identification due to the fastidious nature of some M. bovis isolates, which can result in considerable delays in patient treatment. Finally, isolation and susceptibility testing of M. bovis isolates are significantly less frequently performed in less well developed countries where tuberculosis is a more common human disease than in the United States. 12 Human transmission of this endemic zoonosis is not common, although risks do exist. People that handle the potentially infected animals and their viscera, such as hunters, farmers, veterinarians, slaughterhouse workers, and taxidermists are all considered to be at increased risk of exposure. Other at-risk occupations include laboratory professionals, researchers, and others who might handle the infected tissues or M. bovis isolates. Education about biosafety measures to decrease exposure risks is crucial to prevention of additional human cases. To date, the state of Michigan has been diligent in its public outreach and education program. Hunters and farmers have access to literature (annual hunting guides), safety procedures, web pages dedicated to the disease, lectures, and free tuberculosis testing for harvested wild white-tailed deer. In addition, a number of regulations are in effect to control the spread of this disease. The extensive tuberculosis surveillance and eradication program includes annual testing of hunter-harvested animals, a ban on baiting and feeding in the endemic area, and distribution of antlerless permits in an effort to reduce the white-tailed deer population. Additionally, state agencies such as the Michigan Department of Community Health work rapidly to confirm any potential human cases of M. bovis.
Since the results of this study indicate no antimicrobial resistance present in the Michigan strain of M. bovis, with the exception of expected PZA resistance, this is a welcome finding for public health officials. However, the development of MDR strains of tuberculosis is a worldwide problem that has led M. bovis to be recognized as a reemerging pathogen. 7 MDR strains of M. bovis have been associated with human cases in European countries with genotypes matching both medical and veterinary isolates. 5 These MDR strains are especially problematic in immunosuppressed people as well as in hospital settings serving as nosocomial infections. 5, 12 Therefore, the authors recommend continued periodic monitoring of M. bovis isolates for development of antimicrobial resistance.
